(redirected from Ribonucleic Acid Interference)
Also found in: Medical.
RNAiRibonucleic Acid Interference
References in periodicals archive ?
(Nasdaq: DRNA) (the 'Company' or 'Dicerna'), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today reported financial results for the second quarter ended June 30, 2019 and provided a corporate update.
The work done at UMass has certainly earned plaudits in the science community and in the public forum, none more prominent than the 2006 Nobel Prize in Medicine shared by Craig Mello of UMass and Andrew Fire at Stanford for their work on ribonucleic acid interference and gene silencing.
- US-based investigational ribonucleic acid interference therapeutics developer Dicerna Pharmaceuticals, Inc.